Family · Pharmaceutical analytical standards
Efavirenz
A non-nucleoside reverse transcriptase inhibitor (NNRTI) against HIV, approved in the United States in 1998 and in the European Union in 1999: it is used together with other antiretrovirals, also combined in a single tablet. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It does not occupy the active site of reverse transcriptase but wedges into a nearby pocket, changing the enzyme's shape and blocking it from the outside.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
